Trials / Unknown
UnknownNCT02903043
Expression of miR-204 and Consequences on Capillarization in Limb Muscles of Patients With COPD
Expression of miR-204 and Consequences on Capillarization in Limb Muscles of Patients With Chronic Obstructive Pulmonary Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Limb muscle dysfunction, characterized by loss of capillaries, is amongst the most troublesome systemic consequences of chronic obstructive pulmonary disease (COPD) leading to poor functional status and premature mortality. One prevailing hypothesis stipulates that modification in the expression of miR-204 leads to change the regulation of angiogenesis in vastus lateralis of patients with COPD when compared to controls.
Detailed description
The investigators objective is to investigate the impact of COPD on key signaling pathways involved in the muscle angiogenesis. Mild to severe COPD patients and healthy controls will be recruited. All of the investigators patients will undergo a thorough baseline assessment in pulmonary capacity and body composition. Blood sampling and biopsy of the quadriceps will be done. Key proteins and microRNAs of signaling intramuscular pathways involved in angiogenesis will be measured in the quadriceps.
Conditions
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2015-04-01
- Completion
- 2018-02-01
- First posted
- 2016-09-16
- Last updated
- 2017-05-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02903043. Inclusion in this directory is not an endorsement.